[go: up one dir, main page]

NO980630D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO980630D0
NO980630D0 NO980630A NO980630A NO980630D0 NO 980630 D0 NO980630 D0 NO 980630D0 NO 980630 A NO980630 A NO 980630A NO 980630 A NO980630 A NO 980630A NO 980630 D0 NO980630 D0 NO 980630D0
Authority
NO
Norway
Prior art keywords
chemical connections
connections
chemical
Prior art date
Application number
NO980630A
Other languages
English (en)
Other versions
NO980630L (no
Inventor
David Charles Blakey
David Huw Davies
Robert Ian Dowell
John Frederick Hennam
Peter Robert Marsham
Anthony Michael Slater
Laurent Francois And Hennequin
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9516810.0A external-priority patent/GB9516810D0/en
Priority claimed from GBGB9611019.2A external-priority patent/GB9611019D0/en
Priority claimed from GBGB9612295.7A external-priority patent/GB9612295D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO980630D0 publication Critical patent/NO980630D0/no
Publication of NO980630L publication Critical patent/NO980630L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6899Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO980630A 1995-08-16 1998-02-13 Kjemiske forbindelser NO980630L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9516810.0A GB9516810D0 (en) 1995-08-16 1995-08-16 Chemical compounds
GBGB9611019.2A GB9611019D0 (en) 1996-05-25 1996-05-25 Chemical compounds
GBGB9612295.7A GB9612295D0 (en) 1996-06-12 1996-06-12 Chemical compounds
PCT/GB1996/001975 WO1997007769A2 (en) 1995-08-16 1996-08-13 Chemical compounds

Publications (2)

Publication Number Publication Date
NO980630D0 true NO980630D0 (no) 1998-02-13
NO980630L NO980630L (no) 1998-04-07

Family

ID=27267862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980630A NO980630L (no) 1995-08-16 1998-02-13 Kjemiske forbindelser

Country Status (19)

Country Link
US (1) US6436691B1 (no)
EP (1) EP0844885A2 (no)
JP (1) JPH11511970A (no)
KR (1) KR19990036383A (no)
CN (1) CN1193278A (no)
AU (1) AU707689B2 (no)
BR (1) BR9610050A (no)
CA (1) CA2227040A1 (no)
CZ (1) CZ43098A3 (no)
GB (1) GB2317387B (no)
HU (1) HUP9900062A3 (no)
IL (1) IL123271A0 (no)
MX (1) MX9800967A (no)
NO (1) NO980630L (no)
NZ (1) NZ315713A (no)
PL (1) PL325017A1 (no)
SK (1) SK19498A3 (no)
TR (1) TR199800233T1 (no)
WO (1) WO1997007769A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11511970A (ja) 1995-08-16 1999-10-19 ゼネカ・リミテッド 化学化合物
GB9703201D0 (en) * 1997-02-15 1997-04-02 Zeneca Ltd Chemical compounds
GB9709421D0 (en) * 1997-05-10 1997-07-02 Zeneca Ltd Chemical compounds
CA2355402A1 (en) * 1998-12-21 2000-06-29 Eli Lilly And Company Recombinant synthesis of beta-lipotropin and other peptides
EP1220864A4 (en) * 1999-09-17 2003-05-21 Genzyme Transgenics Corp TRANSGENICALLY PRODUCED FUSION PROTEINS
WO2006035008A1 (de) * 2004-09-27 2006-04-06 Merck Biosciences Ag Rekombinante carboxypeptidase b
WO2010009074A2 (en) * 2008-07-14 2010-01-21 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Method for predicting and detecting tumor metastasis
EP2350286B1 (en) * 2008-10-07 2016-07-20 The Regents of The University of California Recombinant nell protein production
JP7574821B2 (ja) * 2022-03-29 2024-10-29 横河電機株式会社 複合体の製造方法、微生物の混入の有無を判別する方法及び、混入した微生物の同定を行う方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364934A (en) 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human early thymocyte antigen and methods for preparing same
HU190129B (en) * 1983-07-11 1986-08-28 Reanal Finomvegyszergyar,Hu Process for the isolation of carboxypeptidase b enzyme from mammal pancreas
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
GB8809616D0 (en) 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
US5632990A (en) 1988-04-22 1997-05-27 Cancer Research Campaign Tech. Ltd. Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
DK0454783T3 (da) 1989-01-23 1995-10-16 Akzo Nobel Nv Sted-specifik in vivo aktivering af terapeutiske lægemidler
US5433955A (en) 1989-01-23 1995-07-18 Akzo N.V. Site specific in vivo activation of therapeutic drugs
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
EP0625205A1 (en) 1992-01-30 1994-11-23 Genzyme Limited Chiral synthesis with modified enzymes
US6187579B1 (en) * 1993-10-28 2001-02-13 Carlsberg A/S Customized proteases
GB9323429D0 (en) * 1993-11-12 1994-01-05 Wellcome Found Therapy
US5389537A (en) 1994-01-21 1995-02-14 Wisconsin Alumni Research Foundation Nuclease having altered specificity
CN1095677C (zh) * 1994-12-23 2002-12-11 曾尼卡有限公司 化合物
IL116696A (en) 1995-01-25 1999-08-17 Bio Technology General Corp Production of enzymatically active recombinant carboxypeptidase b
US5837516A (en) * 1995-03-03 1998-11-17 Genentech, Inc. Subtilisin variants capable of cleaving substrates containing basic residues
JPH11511970A (ja) 1995-08-16 1999-10-19 ゼネカ・リミテッド 化学化合物
US5985627A (en) * 1997-02-28 1999-11-16 Carlsberg Laboratory Modified carboxypeptidase

Also Published As

Publication number Publication date
CA2227040A1 (en) 1997-03-06
BR9610050A (pt) 1999-10-13
US6436691B1 (en) 2002-08-20
NZ315713A (en) 1999-08-30
WO1997007769A3 (en) 1997-07-10
WO1997007769A2 (en) 1997-03-06
GB2317387B (en) 1999-08-18
JPH11511970A (ja) 1999-10-19
KR19990036383A (ko) 1999-05-25
GB9726893D0 (en) 1998-02-18
HUP9900062A3 (en) 1999-11-29
CN1193278A (zh) 1998-09-16
PL325017A1 (en) 1998-07-06
HUP9900062A2 (hu) 1999-04-28
NO980630L (no) 1998-04-07
SK19498A3 (en) 1998-09-09
IL123271A0 (en) 1998-09-24
GB2317387A (en) 1998-03-25
EP0844885A2 (en) 1998-06-03
AU6747696A (en) 1997-03-19
CZ43098A3 (cs) 1998-05-13
MX9800967A (es) 1998-11-29
TR199800233T1 (xx) 1998-06-22
AU707689B2 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
NO980154D0 (no) Kjemiske forbindelser
NO20002359D0 (no) Kjemiske forbindelser
NO20002360D0 (no) Kjemiske forbindelser
NO20002361D0 (no) Kjemiske forbindelser
LV11618A (lv) Jauni savienojumi
NO954681D0 (no) Kjemiske forbindelser
ATA135896A (de) Skibob
NO951433D0 (no) Kjemiske forbindelser
NO980630D0 (no) Kjemiske forbindelser
ATE198470T1 (de) Alkenyl-benzoylguanidine
NO962264D0 (no) Kjemiske forbindelser
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
KR970013941U (ko) 납골단지
NO964809D0 (no) Kjemiske forbindelser
FI101773B (fi) Apuväline
KR960030307U (ko) 다시
KR970000420U (ko) 구급약품 케이스
NO921004L (no) Kjemiske forbindelser
BR7500991U (pt) Caríndio
BR7501303U (pt) Dupla-embalagem
BR7501299U (pt) Geladeira-prática
BR7500838U (pt) Vassourágua
BR7500825U (pt) Chutegol
BR7500809U (pt) Tele-negocios